
A: Use of a lower cut-off value for HbA1c to predict postoperative renal
complication risk in patients undergoing coronary artery bypass grafting. J
Cardiothorac Vasc Anesth 2013; 27:1167–73)
ii. Glycemic variability, a standard deviation of all POC-BG readings, is associated
with increased postoperative LOS-ICU, rise in creatinine, and AKI - (Bansal B,
Carvalho P, Mehta Y, Yadav J, Sharma P, Mithal A, Trehan N: Prognostic
significance of glycemic variability after cardiac surgery. J Diabetes Complications
2016; 30:613–7)
iii. A study including 761 cardiac surgery patients and found that diabetics were at
increased risk of infection and glucose control (120-160 mg/dL) reduced the risk
of wound infection in diabetics - (Hruska LA, Smith JM, Hendy MP, Fritz VL,
McAdams S. Continuous insulin infusion reduces infectious complications in
diabetics following coronary surgery. Journal of cardiac surgery.
2005;20(5):403-407.)
iv. In a randomized controlled trial, moderate glucose control defined as 127-179
mg/dl was found to be preferable to tight control ≤ 126 in patients undergoing
CABG - (Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL,
Ailawadi G: Superiority of moderate control of hyperglycemia to tight control in
patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg
2011; 141:543–51)
v. Incidence of AKI was higher in patients with time-weighted average intraop
glucose of >150mg/dl (8%) as compared to patients with blood glucose 110-150
mg/dl (3%) - (Song JW, Shim JK, Yoo KJ, Oh SY, Kwak YL: Impact of intraoperative
hyperglycaemia on renal dysfunction after off-pump coronary artery bypass.
Interact Cardiovasc Thorac Surg 2013; 17:473–8)
vi. KDIGO - recommends maintaining blood glucose between 110 - 149 mg/dL in
critically ill patients - (KDIGO. 2012. “KDIGO 2012 Clinical Practice Guideline for
the Evaluation and Management of Chronic Kidney Disease.”
https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.)
vii. Tight glucose control (<150mg/dl) is seen as controversial as risks of
hypoglycemia are significant: NICE-SUGAR meta-analysis - (NICE-SUGAR Study
Investigators, Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo
R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur
C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco
JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J
Med 2009; 360:1283–97)
viii. Society of Thoracic Surgeons (STS) Practice Guidelines recommend maintaining
serum glucose levels ≤ 180 mg/dL for at least 24 hours after cardiac surgery -
(Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR,
Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ, Society of
Thoracic Surgeons Blood Glucose Guideline Task Force: The Society of Thoracic
Surgeons practice guideline series: Blood glucose management during adult
cardiac surgery. Ann Thorac Surg 2009; 87:663–9)
ix. Guidelines for Perioperative Care in Cardiac Surgery from the Enhanced
Recovery After Surgery Society recommends treatment of blood glucose
>160-180mg/dL with an insulin infusion - (Engelman DT, Ben Ali W, Williams JB,
Perrault LP, Reddy VS, Arora RC, Roselli EE, Khoynezhad A, Gerdisch M, Levy JH,
Lobdell K, Fletcher N, Kirsch M, Nelson G, Engelman RM, Gregory AJ, Boyle EM:
Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After
Surgery Society Recommendations. JAMA Surg 2019